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In Vitro Cytotoxic and Antiproliferative Effects of Portulaca oleracea Methanol 
Extract on Breast, Cervical, Colon and Nasopharyngeal Cancerous Cell Lines
(Sitotosik In Vitro dan Kesan Perencatan Proliferatif oleh Portulaca oleracea Pati Metanol Terhadap Sel Kanser 
Payudara, Serviks, Kolon dan Nasofarinks)
GEK Choo SArAh TAN, KAr MuN WoNG, Gui Qi PEArLE-WoNG, SiAu Li YEo, 
SWEE KEoNG YEAP, BEoW ChiN YiAP & huEh ZAN ChoNG*
ABSTrACT
Portulaca oleracea is a ubiquitous garden weed that has been traditionally used as antidiabetic and anti-inflammation 
agent. However, the potential anti-proliferative and cytotoxic effects of  Portulaca oleracea towards cancerous cells are 
still unclear. Human hormone dependent breast cancer MCF-7 cell, colon cancer HT-29, cervical cancer Hela cell and 
nasopharyngeal cancer CNE-1 cell were used in this study. P. oleracea was extracted using methanol and the cytotoxicity 
against various cancerous cell lines was evaluated using 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide solution (MTT) assay. The antiproliferation effect and cell cycle arrest were assessed using BrdU proliferation 
assay and flow cytometry cell cycle RNase/PI analysis, respectively. Portulaca oleracea methanol extract was able 
to reduce viability of all the tested cancerous cell lines. However, IC50  was only observed in CNE-1 cell (92 μg/mL). 
BrdU incorporation assay indicated anti-proliferation of Portulaca oleracea treated MCF-7 cells in a dose-dependent 
manner. A significant increase in the sub G0/G1cell population phase observed by cell cycle analysis indicates the 
occurrence of apoptotic events. In conclusion, Portulaca oleracea showed anti-proliferative effect on CNE-1, HeLa 
and HT-29 and DNA fragmentation on MCF-7 cells. 
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ABSTrAK
Portulaca oleracea adalah sejenis rumpai taman yang digunakan secara tradisi sebagai agen antidiabetik dan anti-
keradangan. Walau bagaimanapun, kesan potensi anti-proliferatif dan sitotosik Portulaca oleracea terhadap sel-sel kanser 
masih tidak jelas. Sel kanser payudara yang bergantung kepada hormon MCF-7, sel kanser kolon HT-29, sel kanser serviks 
Hela dan sel kanser nasofarinks CNE-1 telah digunakan dalam kajian ini. Portulaca oleracea telah diekstrak dengan metanol 
dan kesan sitotosiknya terhadap pelbagai jenis kanser telah dikaji menggunakan pengasaian 3-(4,5-Dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide solution (MTT). Kesan anti-proliferatif dan tangkapan kitaran sel telah dinilai melalui 
pengasaian BrdU dan analisis kitaran sel Rnase/PI menggunakan aliran sitometri. Metanol ekstrak Portulaca oleracea 
dapat mengurangkan kebolehhidupan untuk kesemua sel kanser yang diuji. Akan tetapi, IC50 hanya dapat diperoleh 
pada sel CNE-1 (92 µg/mL). Pengasaian BrdU menunjukkan kesan anti-percambahan oleh Portulaca oleracea terhadap 
sel MCF-7 adalah bergantung kepada kepekatan. Peningkatan sel populasi yang ketara pada fasa G0/G1 telah didapati 
pada analisis kitaran sel menandakan berlakunya apoptosis. Kesimpulannya, Portulaca oleracea menunjukkan kesan 
anti-proliferatif terhadap sel CNE-1, Hela dan HT-29 dan kesan DNA fragmentasi terhadap sel MCF-7. 
Kata kunci: BrdU; kitaran sel; MCF-7; Portulaca oleracea
iNTroDuCTioN
The application of ethnopharmacology and complimentary 
alternative medicine in combating current health issues is 
eminent. Numerous studies have evaluated the biological 
activities of various phytochemicals produced by plants, 
particularly the anti-proliferative and cell cycle regulatory 
effects, in relation to cancer prevention (Cheng et al. 2011; 
Chu et al. 2002; Zhang et al. 2005). Portulaca oleracea 
or commonly known as Purslane or ‘gelang pasir’ in 
Malaysia, falls under the family of Portulacaceae. it is 
an annual sprawling succulent weed with thick, hairless 
red stems, obovate leaves and small yellow flowers 
that widely grows in tropical and subtropical regions 
(Chan et al. 2000; Dweck 2001; Global information 
hub on integrated Medicine 2011). Portulaca oleracea 
is a fascinating plant recognised in most cultures for its 
extensive nutritional benefits. It has been used traditionally 
as a vegetable for human consumption. on the other hand, 
traditional medicinal systems of China, india, Europe and 
Middle Eastern countries have used P. oleracea to treat 
various human ailments such as haemorrhoids, burns and 
wounds, pain, headache, scurvy, fever and urinary disorder. 
Therefore, this edible vegetable is dubbed the ‘global 
panacea’ (Bosi et al. 2009).
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 Extensive modern pharmacological studies have 
attested its wide range of biological effects. it was reported 
to contain a high antioxidant property (Dkhil et al. 2011; 
Lim & Quah 2007; Sulaiman et al. 2011), which is mainly 
attributed to the rich source of omega-3 polyunsaturated 
fatty acids (Oliveira et al. 2009) and flavonoid compounds; 
particularly kaempferol, apigenin, myricetin, quercetin, 
luteolin, carotene and alkaloids (Liu et al. 2000; Xiang et 
al. 2005; Xu et al. 2006). Studies have also shown that the 
plant possesses significant analgesic and anti-inflammatory 
activities when compared with synthetic drugs (Sanja et 
al. 2009). This claimed support the traditional use of this 
plant in treating ulcers and inflammations. Moreover, 
this plant is reported to have hepatoprotective (Ahmida 
2010), neuropharmacological (radhakkrishnan et al. 
2001), antihyperglycemia (Gong et al. 2009), antibacterial 
(rashed et al. 2003) and even bronchodilatory effects 
(Boskabady et al. 2004). Nevertheless, the anti-proliferative 
effect of Portulaca oleracea has rarely been reported. 
however, Chen et al. (2010) reported that water soluble 
polysaccharides isolated from this plant possesses mild 
cytotoxic activity against cervical cancer heLa cell line and 
the sulphated form of these polysaccharides enhances the 
anti-tumour effect (Chen et al. 2010). in addition, luteolin 
which can be found from P. oleracea was previously 
proved to induce cell cycle arrest and apoptosis of colon 
cancer hT-29 cell via decreased of iGF-ii production 
and downregulated insulin-like growth factor-i receptor 
signaling (Lim et al. 2007, 2012). 
 Many of these researches have verified the 
importance of P. oleracea. Furthermore, with its high 
ethnopharmacological values and the present of cytotoxic 
polysaccharides and flavonoid especially luteolin, it is a 
promising plant in the investigation of cancer prevention. 
The aim of this study was to investigate the cytotoxicity 
and antiproliferative effect of Portulaca oleracea towards 
human breast, cervical, colon and nasopharyngeal cancer 
cells. 
MATEriALS AND METhoDS
PLANT MATEriAL AND EXTrACTioN
A commercially available extract of Portulaca oleracea 
(Protusana) was purchased from Frutarom, Switzerland. 
The capsules containing 60 mg of the powdered herb 
extract were stored in an air tight container at room 
temperature for further use. Twenty grams of the powdered 
herb was extracted thrice by absolute methanol (Fisher 
Scientific, uK) at room temperature for 72 h. The extracts 
were then filtered and subjected to evaporation in a rotary 
evaporator at 40ºC. From the initial 20 g of Portulaca 
oleracea powder, a yield of 66.2% of crude methanolic 
extract was obtained. The residual crude extract was 
weighed dissolved in DMSo (dimethyl sulfoxide solution) 
and stored at room temperature. 
CANCEr CELL LiNES
Breast cancer MCF-7, cervical carcinoma cells, heLa, 
colon cancer hT-29, nasopharyngeal CNE-1 and normal 
Chang liver cell were obtained from the Tissue Culture 
Laboratory, iMu. The entire tested cells were below 20 
passages. Change liver cell line was used as a normal cell 
control to determine the selectivity of the extract against 
cancerous cell line. The cells were maintained in rPMi 
1640 medium supplemented with 10% Foetal Bovine 
Serum (PAA, Austria) and 5% penicillin/streptomycin 
(PAA, Austria). 
MTT CELL ViABiLiTY ASSAY
All cell lines were seeded in a flat 96-well plate (Becton-
Dickinson, uS) at a concentration of 1×105 cells/well. The 
cultured cells were then treated with P. oleracea  extract 
at concentrations between 0 and 100 μg/mL for 72 h. 
After 72 h, 1 μg/mL of 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) solution (Sigma 
Aldrich, uSA) was added to all well and all the plates 
were further incubated for another 4 h. Lastly, DMSo was 
added to dissolve the formazan crystals. The absorbance 
was measured at 570 nm (reference wavelength: 630 nm) 
(opsys Mr, Dynex Technologies, uSA). Anthracycline 
antibiotic Doxorubicin was used as a positive control. Cell 
viability was calculated using the following formula: 
 A percentage inhibition curve was plotted against 
the corresponding concentrations and the half maximal 
inhibitory concentration (iC50) was determined.
BroMoDEoXYuriDiNE (BrDu) ProLiFErATioN ASSAY
The anti-proliferative effect of P. oleracea extract (60 
and 80 μg/mL) against CNE-1, heLa, hT-29 and MCF-7 
cells was determined using Brdu proliferation assay 
(roche, Germany, Cat. no. 11647229001) according to 
manufacturer’s protocol. Briefly, cells were seeded in a 
flat 96-well plate at a concentration of 1×105 cells/well and 
treated with 60 and 80 μg/mL of the extract for 48 and 72 
h, respectively. The bromodeoxyuridine solution (Brdu) 
labelling solutions were then added. The absorbance was 
measured at 540 nm by a microplate reader. The percentage 
of cells in the S phase was calculated using the following 
formula:
FLoW CYToMETrY CELL CYCLE ANALYSiS
CNE-1, heLa, hT-29 and MCF-7 cells were seeded in 
6-well plate (Nunc, Denmark) at a concentration of 2×105 
cells/mL and treated with 60 μg/mL of the P. oleracea 
extract for 36 and 60 h. After the incubation periods, the 
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cells were harvested and fixed in 80% absolute ethanol 
and stored at -20ºC for 72 h. Prior to analysis, the cells 
were stained with staining solution (500 μL of PBS, 0.1% 
TritonX, 10 mM EDTA, rNAse (50 μg/mL), Pi (2 μg/mL)) 
and were further incubated on ice for 30 min in the dark. 
The stained cells were then analysed by flow cytometer 
(FACSCalibur, Becton-Dickinson, uSA) at 488 nm. The 
data from 10000 events was collected and processed 
using CellQuest Pro software.
STATiSTiCAL ANALYSiS 
All the assays were performed in triplicate. All values 
were presented as mean ± standard deviation (SD). 
Statistical comparisons were analysed by one-way analysis 
of variance (ANoVA) using Dunnett’s test for multiple 
comparisons (SPSS software version 18.0). Differences 
were considered significant at p<0.05.
rESuLTS
EFFECTS oF PORTULACA OLERACEA EXTrACT 
oN CELL ViABiLiTY
Methanolic extract of Portulaca oleracea showed an 
inhibitory effect towards all the tested cancerous cells 
compared with normal cells after 72 h treatment (Figure 
1). however, iC50 was only obtained in extract treated 
CNE-1 cell at 92 μg/mL. When compared to the positive 
control doxorubicin, iC50 of doxorubicin was much lower 
in all the tested cell lines (CNE-1: 0.25 μg/mL; HeLa: 0.14 
μg/mL; hT-29: 1.2 μg/mL; MCF-7: 0.35 μg/mL; Chang 
Liver: 21 μg/mL). 
EFFECTS oF PORTULACA OLERACEA EXTrACT oN CELL 
ProLiFErATioN
Brdu proliferation analysis, performed in a time- and 
dose-dependent manner, showed a significant decrease 
(p<0.05) of BrdU-labelled cells with both 60 and 80 μg/mL 
of the extract on CNE-1, heLa and hT29 cells (Figure 2). 
The results showed better reduction of cells proliferation 
in CNE-1 and heLa but not MCF-7 and hT-29 at 48 h as 
compared with 72 h. P. oleracea extract inhibited highest 
percentage of cell proliferation over CNE-1 cell at 48 and 
on hT-29 at 72 h as compared with other types of cell. 
EFFECTS oF PORTULACA OLERACEA EXTrACT oN CELL 
CYCLE DiSTriBuTioN
in correlation to the cell proliferation assay which 
demonstrated a decreased proportion of proliferating 
cells after P. oleracea treatment, we next studied the 
effects of P. oleracea on cell cycle progression based on 
their DNA ploidy of all the tested cancerous cells using 
rNase/Pi staining prior to the flow cytometric analysis. 
At both 36 and 60 h of treatment, a significant increase 
(p<0.05) in the proportion of CNE-1 and heLa cells at 
the S phase was seen as compared with their respective 
untreated control suggesting retardation in progression 
of cells through the S phase (Figure 3 & Table 1). For 
hT-29, after 36 and 60 h treatment, significant decrease in 
the S and G2/M phases couple with accumulation of cells 
in G1 phase were observed. This effect suggests that the 
reduction in cell viability and proliferation on hT-29 was 
caused by cytostatic G1 phase arrest without induction of 
apoptosis. Unlike other types of cells, significant increase 
of cell population at hypo-diploid population of subG0/G1 
FiGurE 1. Effects of P. oleracea methanol extract in CNE-1, heLa, hT-29, MCF-7 and Chang Liver cells viability. After 
seeding of cells in 96 well plates overnight, P. oleracea methanol extract was added to the final concentrations shown in 
the figure. Effect of P. oleracea methanol extract after 72 h against the viability of treated cells was evaluated through 
mitochondrial activity using MTT assay. Each value represents the means ±S.E.M. triplicate in three independent 
experiments. The differences between the untreated control group and treated group 
were determined by one-way ANoVA (*p≤0.05).
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phase was observed in MCF-7 cell treated with P. oleracea 
extract for both 36 and 60 h. This result indicated that the 
extract was able to induce DNA fragmentation which is the 
hallmark for apoptosis. 
DiSCuSSioN
recently, experts in cancer prevention, detection and 
treatment have reviewed the need of more research in 
chemoprevention (Follen et al. 2003). Thus, relevant 
approaches particularly food-based entities remain 
essential in reducing the risk of cancer. P. oleracea, an 
ubiquitous garden weed has shown to provide a rich plant 
source of nutritional benefits. With that, the potential 
anti-proliferative activities of standardized P. oleracea 
methanol extract towards various types of cancerous cells 
were explored. These were determined through MTT assay, 
Brdu incorporation assay and flow cytometry rNAse/Pi 
staining to quantify on the cell cycle progression. 
 MTT assay that is commonly used to screen for the 
cell proliferation, viability and cytotoxic effects was 
done to determine the cell viability by assessing healthy 
cells (radhakkrishnan et al. 2001). under the current 
experimental conditions, no iC50 was obtained within 
the range of the tested concentration (0 – 100 μg/mL) on 
all the cell lines except for CNE-1. however, there was a 
significant decline in cell viability at concentrations higher 
than 40 μg/mL (Figure 1). The reduction of cell viability as 
compared with untreated control cell may be contributed 
by apoptosis or antiproliferation. on the other hand, the 
extract showed selective inhibition on all the cancerous cell 
as compared with Chang liver cells, which indicates the non 
toxic effect of the plant and is safe for daily consumption. 
Brdu assay is a method to quantify cell proliferation in 
which Brdu, a thymidine analogue, incorporates during 
DNA synthesis and gives a direct measurement of cells 
undergoing proliferation. The extract showed a significant 
inhibition of DNA synthesis on CNE-1, heLa and hT-29 
cells but not on MCF-7. This effect was further evaluated 
by quantifying the cell cycle progression of all tested 
cancerous cell lines using flow cytometric analysis. 
 From our results, accumulation of cells at S phase 
was observed in CNE-1 and heLa cells treated with the 
P. oleracea extract (Figure 3 & Table 1). This result 
indicated that the extract was able to reduce DNA synthesis 
that was detected in Brdu assay and arrest both CNE-1 
and heLa cell under S phase of the cell cycle. Various 
plant-based phytochemicals have been reported to arrest 
cancer cells in the S phase, in agreement to this current 
finding (Srivastava et al. 2009; Zhang et al. 2011). 
This similarity may be contributed by comparable 
phytochemicals found among the plants with P. oleracea. 
Those phytochemicals present in P. oleracea included 
omega-3 fatty acids, β-carotene, flavonoids and alkaloids 
(Liu et al. 2000; Xiang et al. 2005; Xu et al. 2006). Some 
of these compounds are known to cause cell cycle arrest 
in cancer cells from other reports (Androutsopoulos et al. 
2010; Casagrande & Darbon 2001; Zhang et al. 2009). For 
example, Chen et al. (2010) demonstrated a significant 
increase of cells in the S phase which led to the S phase 
arrest and an apoptotic phenomenon, when heLa cells 
were treated with P. oleracea sulphated-polysaccharides. 
Besides, alkaloids extract from Scutellaria barbata were 
found to arrest cells at S phase of the cell cycle. The 
extract was also found to induce apoptosis leading to cell 
death (Wang et al. 2011).
 unlike CNE-1 and heLa cell, cell cycle analysis 
of hT-29 suggests that P. oleracea may exert its anti-
proliferative effects in hT-29 cells by arresting the 
cell at G1 phase. Cell cycle progression of P. oleracea 
treated hT-29 was observed with significant G0/G1 
arrest at 72 h and Brdu proliferation assay was observed 
FiGurE 2. Effects of P. oleracea methanol extract in CNE-1, heLa, hT-29, MCF-7 and Chang Liver cells DNA 
synthesis. After seeding the cell in 96 well plates for overnight, P. oleracea methanol extract were added to the 
final concentrations shown in the figure. Effect of P. oleracea methanol extract after 48 and 72 h against the 
DNA synthesis of treated cells was evaluated through Brdu proliferation assay. Each value represents the means 
±S.E.M. triplicate in three independent experiments. The differences between the untreated control 
group and treated group were determined by one-way ANoVA (*p≤0.05).
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FiGurE 3. Cell cycle histogram for the effects of P. oleracea methanol extract (60 μg/mL) on cell cycle distribution of CNE-1 
(a-d), heLa (e-h), hT-29 (i-l) and MCF-7 (m-p) cells after 36 and 60 h were determined by rNase/Pi cell cycle flow cytometry. 
G0/G1, G2/M and S indicate the cell phase and sub- G0/G1 DNA content refers to the proportion of apoptotic cells undergoing 
DNA fragmentation. The detail percentage of the cell cycle progress was summarized in Table 1
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higher inhibition in 72 h. This G1 arrest after 72 h may 
be contributed by the present of flavanoids especially 
luteolin (Xu et al. 2006). Due to its hydrophilic nature, 
the intestine is often exposed to superior concentrations 
of dietary polyphenols compared to other body tissues, 
making it a potential chemopreventive site (Manach et 
al. 2004). Luteolin, one of the flavonoids found in P. 
oleracea¸ induced a G1 arrest in the cell cycle progression 
of hT-29 cells by reducing cyclin D1 and phosphorylated 
retinoblastoma protein levels, as well as decreasing CDK2 
and CDK4 activity (Lim et al. 2007, 2012). 
 Since DNA fragmentation is the hallmark for apoptosis, 
mild reduction of the MCF-7 viability as seen in the MTT 
assay indicates induction of apoptosis by the extract as 
shown in the cell cycle analysis (Figure 3 & Table 1). 
This apoptotic event may be contributed by the presence 
of β-carotene, omega-3 fatty acids, coumarins, flavonoids, 
monoterpene glycosides, anthraquinone glycosides and 
alkaloids in P. oleracea that have been previously proved 
to exhibit the induction of apoptosis in some previous 
researches (Li et al. 2009; Xiang et al. 2005; Xin et al. 
2008). in addition, polysaccharides that were found to 
be rich in P. oleracea (Mangalan et al. 1989) have been 
demonstrated to mediate apoptotic phenomenon towards 
MCF-7 cells via dysregulating the Bcl-2 and Bax proteins 
in MCF-7 cells (Yang et al. 2006). 
CoNCLuSioN
in conclusion, our data indicated that the Portulaca oleracea 
extract specifically reduced viability of various cancerous 
cell lines either through G0/G1 or S phase arrest (on CNE-1, 
heLa and hT-29 cells) or via induction of sub-G0/G1 DNA 
fragmention (on MCF-7). however, the mechanism of the 
action is still unclear. Thus, further investigations including 
isolation of individual active flavonoid and elucidation 
of the molecular mechanisms involved are needed to 
fully understand the active ingredient and potential of P. 
oleracea as a chemopreventive food. 
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